Corneal Regeneration in Japan
What is Corneal Regeneration?
The cornea, the clear window at the front of your eye, is vital for sharp vision. When damaged by disease, injury, or infection, traditional treatments like corneal transplantation have long been the standard of care. However, new horizons are emerging. Corneal regeneration is a groundbreaking approach to repairing or replacing damaged corneal tissue using advanced cellular therapies. The goal is to restore the function of damaged cells and tissue, offering new hope for conditions previously considered untreatable.
Who is a Candidate for Corneal Regeneration?
Candidates for regenerative corneal therapies are typically individuals with severe corneal diseases that have led to irreversible vision loss. Eligibility is determined by a thorough medical evaluation, but key conditions often include:
-
Limbal Stem Cell Deficiency: A condition where the corneal surface cannot regenerate properly due to trauma or disease.
-
Corneal Endothelial Dystrophies: Conditions like Fuchs' endothelial dystrophy, where the inner cell layer of the cornea degenerates, causing swelling and clouding.
-
Bullous Keratopathy: Swelling of the cornea, often following previous glaucoma surgery or other intraocular surgeries.
Japan's Leadership
Japan has firmly established itself as a global leader in the field of regenerative medicine, primarily due to its pioneering role in iPS cell therapy and its commitment to translating research into clinical practice.
-
Pioneering iPS Cell Therapy
-
Japan is the birthplace of induced pluripotent stem (iPS) cell technology, a breakthrough that earned Professor Shinya Yamanaka the Nobel Prize. These revolutionary cells, created by reprogramming adult cells, can be differentiated into almost any cell type—including the specific corneal cells needed to restore vision. This groundbreaking research has led to therapies for both the corneal surface and its inner layer. Notably, in Japan, researchers have successfully developed iPSC-derived corneal endothelial cell therapies to treat conditions like Fuchs' endothelial dystrophy, a major cause of corneal swelling and vision loss. This innovative approach aims to replace damaged endothelial cells and restore the cornea's clarity. This technology has paved the way for therapies that can directly address the root cause of corneal degeneration.
-
-
Clinical Application of Corneal Epithelium Regeneration
-
Japanese researchers have been at the forefront of translating corneal epithelial regenerative therapy into clinical practice. Pioneering treatments like Nepic (Cultured Autologous Limbal Epithelial Cell Sheet) and Sakracy (Cultured Autologous Oral Mucosal Epithelial Cell Sheet) were developed here. These therapies offer new hope by using a patient's own cells to regenerate the damaged corneal surface, reducing the risk of immune rejection and providing a robust solution for severe ocular surface diseases.
-
Read Invited Expert Articles

Cornea Regeneration: Regenerative Medicine for Challenging Corneal Diseases
Fujita Health Univ. Haneda Clinic
Director, Prof. Shigeto Shimmura, MD, PhD
Eligibility Determination Processes
Due to the complexity of retinal regeneration, a comprehensive assessment is crucial to determine if a patient is a suitable candidate.
-
Expert Review
-
A team of experts will meticulously review all medical records and diagnostic images to confirm the diagnosis and determine the stage of the disease. This is a crucial step for assessing eligibility.
-
Our Medical Concierge Services
-
What to Expect from Our Services
-
We are your dedicated partner throughout your eligibility determination for corneal regeneration in Japan. Our physician-led team ensures every step is guided by expert medical understanding, from your initial consultation to destination choice.
-
-
Service Flow
-
Initial Review: Start by completing our secure inquiry form on this page. Tell us about your situation and what you seek from our expert doctors.
-
Expert Match: Based on your condition and preferences, our physician-led team will precisely match you with ophthalmology experts from our exclusive network across Japan.
-
Personalized Referrals: We'll propose suitable medical institutions for your treatment in Japan. Our goal is to connect you with the ideal specialist and facility, opening the door for you to experience professional Japanese ophthalmology.
-
Service Fees
-
Email Consultation for Expert Match and Personalized Referrals: Free of Charge
-

